Agilent Technologies, Inc. (A)
NYSE: A · Real-Time Price · USD
121.38
+0.41 (0.34%)
At close: Feb 27, 2026, 4:00 PM EST
120.78
-0.60 (-0.49%)
After-hours: Feb 27, 2026, 7:56 PM EST
Agilent Technologies Revenue
Agilent Technologies had revenue of $1.80B in the quarter ending January 31, 2026, with 6.96% growth. This brings the company's revenue in the last twelve months to $7.07B, up 8.14% year-over-year. In the fiscal year ending October 31, 2025, Agilent Technologies had annual revenue of $6.95B with 6.73% growth.
Revenue (ttm)
$7.07B
Revenue Growth
+8.14%
P/S Ratio
4.86
Revenue / Employee
$390,331
Employees
18,100
Market Cap
34.31B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Oct 31, 2025 | 6.95B | 438.00M | 6.73% |
| Oct 31, 2024 | 6.51B | -323.00M | -4.73% |
| Oct 31, 2023 | 6.83B | -15.00M | -0.22% |
| Oct 31, 2022 | 6.85B | 529.00M | 8.37% |
| Oct 31, 2021 | 6.32B | 980.00M | 18.36% |
| Oct 31, 2020 | Pro | Pro | Pro |
| Oct 31, 2019 | Pro | Pro | Pro |
| Oct 31, 2018 | Pro | Pro | Pro |
| Oct 31, 2017 | Pro | Pro | Pro |
| Oct 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| IQVIA Holdings | 16.31B |
| Labcorp Holdings | 13.95B |
| Quest Diagnostics | 11.04B |
| Illumina | 4.34B |
| IDEXX Laboratories | 4.30B |
| Mettler-Toledo International | 4.03B |
| Exact Sciences | 3.25B |
| Waters | 3.17B |
A News
- 2 days ago - Agilent Technologies, Inc. (A) Q1 2026 Earnings Call Transcript - Seeking Alpha
- 2 days ago - Agilent reports in-line first quarter, says results hurt by US snowstorm - Reuters
- 2 days ago - Agilent Reports First-Quarter Fiscal Year 2026 Financial Results - Business Wire
- 4 days ago - Agilent to Participate in TD Cowen's 46th Annual Health Care Conference - Business Wire
- 16 days ago - Bloomberg's 2026 Watch List Flags 5 Ideal 'Safer' February Dividend Buys - Seeking Alpha
- 16 days ago - Agilent Announces Cash Dividend of 25.5 Cents per Share - Business Wire
- 17 days ago - Agilent Presents Boehringer Ingelheim With Inaugural 2025 Instrument Trade‑In Impact Award - Business Wire
- 17 days ago - Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma (EOC) - Business Wire